BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 36561763)

  • 1. Berberine a traditional Chinese drug repurposing: Its actions in inflammation-associated ulcerative colitis and cancer therapy.
    Zhu C; Li K; Peng XX; Yao TJ; Wang ZY; Hu P; Cai D; Liu HY
    Front Immunol; 2022; 13():1083788. PubMed ID: 36561763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Berberine inhibits dendritic cells differentiation in DSS-induced colitis by promoting Bacteroides fragilis.
    Zheng C; Wang Y; Xu Y; Zhou L; Hassan S; Xu G; Zou X; Zhang M
    Int Immunopharmacol; 2021 Dec; 101(Pt A):108329. PubMed ID: 34749293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxyberberine, a novel gut microbiota-mediated metabolite of berberine, possesses superior anti-colitis effect: Impact on intestinal epithelial barrier, gut microbiota profile and TLR4-MyD88-NF-κB pathway.
    Li C; Ai G; Wang Y; Lu Q; Luo C; Tan L; Lin G; Liu Y; Li Y; Zeng H; Chen J; Lin Z; Xian Y; Huang X; Xie J; Su Z
    Pharmacol Res; 2020 Feb; 152():104603. PubMed ID: 31863867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of anti-inflammatory effects of berberine, and its natural oxidative and reduced derivatives from Rhizoma Coptidis in vitro and in vivo.
    Li CL; Tan LH; Wang YF; Luo CD; Chen HB; Lu Q; Li YC; Yang XB; Chen JN; Liu YH; Xie JH; Su ZR
    Phytomedicine; 2019 Jan; 52():272-283. PubMed ID: 30599908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Berberine as a promising natural compound for the treatment of periodontal disease: A focus on anti-inflammatory properties.
    Mohammadian Haftcheshmeh S; Momtazi-Borojeni AA
    J Cell Mol Med; 2021 Dec; 25(24):11333-11337. PubMed ID: 34719112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Natural Carrier-Free Self-Assembled Nanoparticles for Treatment of Ulcerative Colitis by Balancing Immune Microenvironment and Intestinal Barrier.
    Gao S; Zheng H; Xu S; Kong J; Gao F; Wang Z; Li Y; Dai Z; Jiang X; Ding X; Lei H
    Adv Healthc Mater; 2023 Dec; 12(31):e2301826. PubMed ID: 37681364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Berberine-Loaded Nanostructured Lipid Carriers Enhance the Treatment of Ulcerative Colitis.
    Deng J; Wu Z; Zhao Z; Wu C; Yuan M; Su Z; Wang Y; Wang Z
    Int J Nanomedicine; 2020; 15():3937-3951. PubMed ID: 32581538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low molecular weight fucoidan modified nanoliposomes for the targeted delivery of the anti-inflammation natural product berberine.
    Liu L; Xing R; Xue J; Fan J; Zou J; Song X; Jia R; Zou Y; Li L; Zhou X; Lv C; Wan H; Zhao X; Yin Z
    Int J Pharm; 2023 Jul; 642():123102. PubMed ID: 37277087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preventive and Therapeutic Roles of Berberine in Gastrointestinal Cancers.
    Hu S; Zhao R; Liu Y; Chen J; Zheng Z; Wang S
    Biomed Res Int; 2019; 2019():6831520. PubMed ID: 31950049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effects of berberine hydrochloride on DSS-induced ulcerative colitis in rats.
    Zhu L; Gu P; Shen H
    Int Immunopharmacol; 2019 Mar; 68():242-251. PubMed ID: 30743078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Berberine regulates intestinal microbiome and metabolism homeostasis to treat ulcerative colitis.
    Yang T; Qin N; Liu F; Zhao Y; Liu W; Fan D
    Life Sci; 2024 Feb; 338():122385. PubMed ID: 38184271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Berberine ameliorates TNBS induced colitis by inhibiting inflammatory responses and Th1/Th17 differentiation.
    Li C; Xi Y; Li S; Zhao Q; Cheng W; Wang Z; Zhong J; Niu X; Chen G
    Mol Immunol; 2015 Oct; 67(2 Pt B):444-54. PubMed ID: 26224047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Berberine for gastric cancer prevention and treatment: Multi-step actions on the Correa's cascade underlie its therapeutic effects.
    Liu Q; Tang J; Chen S; Hu S; Shen C; Xiang J; Chen N; Wang J; Ma X; Zhang Y; Zeng J
    Pharmacol Res; 2022 Oct; 184():106440. PubMed ID: 36108874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted delivery of Chinese herb pair-based berberine/tannin acid self-assemblies for the treatment of ulcerative colitis.
    Chen S; Chen Z; Wang Y; Hao W; Yuan Q; Zhou H; Gao C; Wang Y; Wu X; Wang S
    J Adv Res; 2022 Sep; 40():263-276. PubMed ID: 36100331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of berberine in treatment of rheumatoid arthritis: From multiple targets to therapeutic potential.
    Huang DN; Wu FF; Zhang AH; Sun H; Wang XJ
    Pharmacol Res; 2021 Jul; 169():105667. PubMed ID: 33989762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Yeast Microcapsule Mediated Natural Products Delivery for Treating Ulcerative Colitis through Anti-Inflammatory and Regulation of Macrophage Polarization.
    Feng X; Xie Q; Xu H; Zhang T; Li X; Tian Y; Lan H; Kong L; Zhang Z
    ACS Appl Mater Interfaces; 2022 Jul; 14(27):31085-31098. PubMed ID: 35770618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Berberine as a natural modulator of inflammatory signaling pathways in the immune system: Focus on NF-κB, JAK/STAT, and MAPK signaling pathways.
    Haftcheshmeh SM; Abedi M; Mashayekhi K; Mousavi MJ; Navashenaq JG; Mohammadi A; Momtazi-Borojeni AA
    Phytother Res; 2022 Mar; 36(3):1216-1230. PubMed ID: 35142403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Berberine ameliorates DSS-induced intestinal mucosal barrier dysfunction through microbiota-dependence and Wnt/β-catenin pathway.
    Dong Y; Fan H; Zhang Z; Jiang F; Li M; Zhou H; Guo W; Zhang Z; Kang Z; Gui Y; Shou Z; Li J; Zhu R; Fu Y; Sarapultsev A; Wang H; Luo S; Zhang G; Hu D
    Int J Biol Sci; 2022; 18(4):1381-1397. PubMed ID: 35280677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for the complementary and synergistic effects of the three-alkaloid combination regimen containing berberine, hypaconitine and skimmianine on the ulcerative colitis rats induced by trinitrobenzene-sulfonic acid.
    Zhang M; Long Y; Sun Y; Wang Y; Li Q; Wu H; Guo Z; Li Y; Niu Y; Li C; Liu L; Mei Q
    Eur J Pharmacol; 2011 Jan; 651(1-3):187-96. PubMed ID: 20969848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experimental study on effects of berberine combined with 6-shogaol on intestinal inflammation and flora in mice with ulcerative colitis].
    Wei HL; Li JT; Chen ZG; Yan SG
    Zhongguo Zhong Yao Za Zhi; 2022 Aug; 47(16):4418-4427. PubMed ID: 36046871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.